Trial on Early Induction Versus Expectant Management of Nulliparous Women With a Prolonged Latent Phase
NCT ID: NCT01863797
Last Updated: 2013-05-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
138 participants
INTERVENTIONAL
2007-06-30
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Randomized Trial of Induction Versus Expectant Management
NCT01990612
High Dose Versus Low Dose Oxytocin for Augmentation of Delayed Labour
NCT01587625
Induction Versus Expectant Management With Abnormal Maternal Biochemical Markers
NCT02754635
Post Term Pregnancy - Induction of Labor or Monitoring of Pregnancy
NCT00385229
Active Versus Expectant Management of the Third Stage of Labor
NCT00473707
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early induction
Induction was performed if membranes were still intact and cervical dilation was less than four centimetres five hours after medication for therapeutic rest. For participants with an unripe cervix intravaginal prostaglandin E2 (PgE2, dinoproston) was used. A transcervical catheter (BARD) was inserted if this procedure was possible 19 and if cervical dilatation permitted, amniotomy was performed. The physician in charge performed all assessments and procedures except amniotomy.
When the participants reached the active phase they were monitored according to the clinical guidelines.
Early induction
expectant management
The participants in the control group awaited spontaneous onset of labour as long as possible (expectant management). If contractions had ceased or subsided after the therapeutic rest women could be discharged from hospital, but were still included in the study. When reaching the active phase of labour women were monitored according to the clinical guidelines.
Expectant mamagement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early induction
Expectant mamagement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with a singleton fetus in cephalic presentation,
* gestational age between 37+0 and 41+6,
* continuous contractions exceeding 18 hours impeding rest (women's report),
* a cervical dilation of less than four centimetres and intact membranes. Gestational age was confirmed by ultrasound in the first trimester.
Women had to be able to read, understand and speak Swedish.
16 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elena Bräne
RNM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Förlossningen, Danderyd Hospital
Stockholm, Stockholm County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007/65-31/2
Identifier Type: OTHER
Identifier Source: secondary_id
EPN 2007/65-31/2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.